Reaume; Andrew G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reaume; Andrew G..The latest application filed is for "treatment of acute respiratory distress syndrome (ards)".

Company Profile

8.14.25

Reaume; Andrew G. - Exton PA
Reaume, Andrew G. - Waterford CT
Reaume; Andrew G. - West Chester PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating dyskinesia and related disorders Grant 11,351,169 - Ciallella , et al. June 7, 2	2022-06-07
Treatment of Acute Respiratory Distress Syndrome (ARDS) App 20220031700 - Reaume; Andrew G. ; et al.	2022-02-03
Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders App 20210361652 - Reaume; Andrew G. ; et al.	2021-11-25
Methods and formulations for modulating Lyn kinase activity and treating related disorders Grant 11,033,548 - Reaume , et al. June 15, 2	2021-06-15
Treatment Of Adipocytes App 20210128558 - Reaume; Andrew G. ; et al.	2021-05-06
Treatment Of Liver Diseases App 20210106581 - Reaume; Andrew G. ; et al.	2021-04-15
Treatment of adipocytes Grant 10,786,503 - Reaume , et al. September 29, 2	2020-09-29
Prevention of Pancreatic Cell Degeneration App 20200215067 - Reaume; Andrew G. ; et al.	2020-07-09
Treatment Of Type I And Type Ii Diabetes App 20200215068 - Reaume; Andrew G. ; et al.	2020-07-09
Methods Of Treating Dyskinesia And Related Disorders App 20190328736 - Ciallella; John ; et al.	2019-10-31
Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders App 20190321362 - Reaume; Andrew G. ; et al.	2019-10-24
Methods and formulations for modulating Lyn kinase activity and treating related disorders Grant 10,251,883 - Reaume , et al.	2019-04-09
Methods of treating sleep disorders Grant 10,188,651 - Ciallella , et al. Ja	2019-01-29
Treatment Of Adipocytes App 20180289707 - Reaume; Andrew G. ; et al.	2018-10-11
Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders App 20180125845 - Reaume; Andrew G. ; et al.	2018-05-10
Methods and formulations for modulating Lyn kinase activity and treating related disorders Grant 9,763,945 - Reaume , et al. September 19, 2	2017-09-19
Methods Of Treating Dyskinesia And Related Disorders App 20170042894 - Ciallella; John ; et al.	2017-02-16
Methods of treating dyskinesia and related disorders Grant 9,402,830 - Ciallella , et al. August 2, 2	2016-08-02
Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders App 20160136165 - Reaume; Andrew G. ; et al.	2016-05-19
Methods and formulations for treating cardiovascular disease Grant 9,216,959 - Reaume , et al. December 22, 2	2015-12-22
Methods Of Treating Dyskinesia And Related Disorders App 20150231116 - Ciallella; John ; et al.	2015-08-20
Treatment Of Type I And Type Ii Diabetes App 20150190396 - Reaume; Andrew G. ; et al.	2015-07-09
Methods of treating dyskinesia and related disorders Grant 9,051,312 - Ciallella , et al. June 9, 2	2015-06-09
Methods Of Treating Dyskinesia And Related Disorders App 20140371231 - Ciallella; John ; et al.	2014-12-18
Methods and formulations for modulating lyn kinase activity and treating related disorders Grant 8,835,448 - Reaume , et al. September 16, 2	2014-09-16
Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders App 20140163054 - Reaume; Andrew G. ; et al.	2014-06-12
Compounds and methods for treating disorders related to glucose metabolism Grant 8,552,184 - Reaume , et al. October 8, 2	2013-10-08
Prevention Of Pancreatic Beta Cell Degeneration App 20130158055 - Reaume; Andrew G. ; et al.	2013-06-20
Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders App 20130095182 - Reaume; Andrew G. ; et al.	2013-04-18
Methods Of Activating IRS-1 And AKT App 20100197710 - Reaume; Andrew G. ; et al.	2010-08-05
Compounds And Methods For Treating Disorders Related To Glucose Metabolism App 20100004273 - Reaume; Andrew G. ; et al.	2010-01-07
Gene-targeted non-human mammal with human FAD presenilin mutation and generational offspring App 20040154047 - Scott, Richard W. ; et al.	2004-08-05
Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring Grant 6,734,336 - Scott , et al. May 11, 2	2004-05-11
Rapid creation of gene targeting vectors using homologous recombination in yeast App 20030092183 - Fisher, Katherine E. ; et al.	2003-05-15
Gene-targeted non-human mammals deficient in the SOD-1 gene Grant 5,814,300 - Scott , et al. September 29, 1	1998-09-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.